Close
Nordic 9Nordic 9

Amarna Therapeutics (private company)

Netherlands amarnatherapeutics.com
See something wrong or missing? Let us know
Offices:Leiden
Industry:BiotechHealth servicesManufacturing
Business model:B2B

Amarna Therapeutics is a Dutch biotech company using the unique properties SVac for developing next generation effective gene and immune-therapies.

Investors: we tracked 3 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 15.58M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Amarna Therapeutics

Name Criteria
France Xenothera
73%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Sweden Anocca
70%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Sweden Nanolyze
68%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 1
Sweden Pila Pharma
65%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one other investor: found 1
Germany CatalYm
63%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Finland FinnAdvance
63%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
France InnovaFeed SAS
63%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Switzerland Memo Therapeutics
63%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Denmark Octarine Bio
63%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
Spain Peptomyc
63%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Top